MOLCURE

Molcure Inc. | Accelerating drug discovery

MOLCURE was founded in 2013, is headquartered in Japan, and has $7.2M in recorded funding across 2 rounds.

Founded
2013
Business Model
B2B
Total Funding
$7.2M
Last Round
$7.2M Series CAug 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

MOLCURE Inc. is a Japanese AI-powered drug discovery company founded in 2013, focused on accelerating the development of functional antibodies and peptides. Its platform integrates advanced machine learning, next-generation sequencing, bioinformatics, and laboratory robotics to enable true de novo antibody discovery — generating novel, high-affinity candidates without relying on prior experimental data. MOLCURE collaborates with global pharmaceutical partners including Boehringer Ingelheim, and has over 11 years of experience building proprietary antibody data analysis frameworks. The company was co-founded by researchers from Keio University and operates at the intersection of AI, biotech, and drug design.

Summary

MOLCURE is an Artificial Intelligence company based in Japan, founded in 2013. It has raised $7.2M in total across 2 rounds, most recently a $7.2M Series C round in Aug 2021. Investors include Jafco Ventures, GMO Venture Partners and STRIVE.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CAug 2021
$7.2M

Sign up to see all 2 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026
Waymo

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture RoundTotal funding$29.6BFeb 2026
Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MOLCURE on Indexed.vc
<a href="https://indexed.vc/companies/molcure"><img src="https://indexed.vc/api/badge/company/molcure" alt="MOLCURE on Indexed.vc" width="260" height="76" /></a>